YUNNAN, China, Nov. 16, 2006 (PRIMEZONE) -- China Health Management Corp. (CHMC) (Pink Sheets:CNHC), a Nevada Corporation, is pleased to announce that the Company has completed signing a joint venture agreement with Richard Technology Co. Ltd. of China to build Yunnan's first high-end hospital in China. Richard Technology Co. Ltd. (RTCL) is a holding company based in Yunnan, China. RCTL has received exclusive healthcare and medical licenses from federal, provincial and municipal governments of China for operating a hospital and a medical center in Yunnan, China. The Richland International hospital project in Kunming City has commenced construction of its infrastructure and is expecting completion of construction at the end of the first quarter 2007.
About The Company
China Health Management Corp. is Nevada Corporation. The company is a healthcare and management company focused on the operation and management of hospitals and the medical industry in China. The company's goal is to establish a leading position in the high-end medical market in Yunnan Province in three-five years and to secure a 40% market share of the private medical services industry.
Safe Harbor Statement:
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to, price volatility of currency fluctuations; political, operational, and governmental approval and regulation risks in China.